Latest filing published 27 Mar 2024 for ImmunoPrecise Antibodies Ltd., €3,093.
Jennifer Lynne Bath is a declared insider of ImmunoPrecise Antibodies Ltd., with filings sourced from SEDI. Over a trading history stretching from 17 July 2019 to 27 March 2024, the count stands at 138 filings.
No open-market sale appears; the market trades are 136 purchases worth €185k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise. Since January 2024: 9 purchases and no sales on the market.
The median purchase comes to €764. Across 108 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 27 March 2024 with an open-market purchase (€3,093) in ImmunoPrecise Antibodies Ltd. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 137 declarations